Acceptance and Commitment Therapy for Parenting Children With Cerebral Palsy
Effects of Acceptance and Commitment Therapy on Psychological Outcomes and Quality of Life of Parents of Children With Cerebral Palsy: A Randomized Controlled Trial.
The goal of this randomized controlled trial is to evaluate whether a group-based acceptance and commitment therapy (ACT) can improve the psychological outcomes and quality of life (QOL) of children with cerebral palsy. The main questions it aims to answer are:
- Does a group-based ACT improve the psychological flexibility of the participants?
- Does a group-based ACT improve the psychological distress, including depression, anxiety, and stress, of the participants?
- Does a group-based ACT improve the QOL of the participants?
Researchers will compare a group-based ACT to usual/standard care to determine whether ACT improves participants' psychological outcomes and QOL.
Participants will:
- Receive eight weekly, face-to-face, group-based ACT sessions, each lasting approximately 90 minutes.
- Receive home-based practices following each session.
- Receive a weekly phone call assessment to address any study-related concerns and provide reminders for the next appointment or assessment day.
- Complete the questionnaires at three times: baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Kenneth N.K Fong, PhD
- Numéro de téléphone: +852 2766 6716
- E-mail: rsnkfong@polyu.edu.hk
Sauvegarde des contacts de l'étude
- Nom: Tenaw Gualu Melesse, PhD
- Numéro de téléphone: +852 5530 4750
- E-mail: tgmeles@polyu.edu.hk
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Parents of children under 18 years with any type and severity of cerebral palsy
- Able to communicate in Amharic, and
- Able to provide written consent for participation
Exclusion Criteria:
- Participants who have known psychological or psychiatric problems, and
- Participants who are currently participating or have participated in another similar or related study within six months
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: ACT intervention
|
Participants in the intervention group will receive an ACT that consists of eight sessions. Th introductions include an introduction, cognitive defusion, acceptance, being present, values, committed action, and noticing self/self-as context, and a summary session. An ACT-trained researcher will deliver weekly, face-to-face, group-based sessions, each lasting approximately 90 minutes, though durations may vary to accommodate group variations. Each group will consist of five to seven participants. The interventions will be delivered via various strategies, including psychoeducation, discussion, mindfulness exercises, and metaphors supplemented with with home practices. A research assistant will conduct a weekly phone call assessment to address any study-related concerns and provide reminders for the next appointment or assessment day. |
|
Autre: Usual/standard treatment
|
Participants in the control group will receive the usual or standard care provided by the respective center.
To enhance participant retention in the study, a weekly phone call will be conducted by a research assistant, during which participants will be asked whether they have any concerns about the study and reminded of the next appointment or assessment day.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Level of psychological flexibility
Délai: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
|
The psychological flexibility will be assessed using the 7-item Acceptance and Action Questionnaire-II (AAQ-II).
Each item in the AAQ-II is scored on a scale of seven from 1(never true) to 7(always true).
The total score is obtained by summing the scores of all items, and the higher the total score indicates greater psychological inflexibility.
|
Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
|
|
Level of psychological distress
Délai: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
|
The psychological distress outcomes including, anxiety, depression, and stress will be assessed using the self-report 21-item anxiety, depression, and stress scale (DASS-21). Each of the subscales comprises 7 items and is scored on a four-point Likert scale ranging from 0(didn't apply at all to me) to 3(applied to me very much or most of the time), and the score is calculated by summing up the items in each subscale, and the final core is obtained by multiplying the core by two to make it comparable with the full scale (DASS-42). The higher the core indicates high distress symptoms. |
Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Level of quality of life
Délai: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
|
The quality of life will be evaluated by using the World Health Organization Quality of Life-BREF (WHOQOL-BREF). It comprises four domains: physical health, psychological, social relationships, and environment. Each item is scored on a five-point scale from 1 to 5, with varying response options across the domains, and some items need to be reversely scored. There are two items examined separately and will not be included in the score calculation. Domain scores are calculated by summing up the mean of all items in each domain and multiplying by four, and then the total score is transformed to a 0-100 scale to make the domains comparable. A higher the score indicates a higher QOL. |
Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- HSEARS20260707001
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .